Search Page

1

Inflammatory Myofibroblastic Tumor Driven by Novel NUMA1-ALK Fusion Responds to ALK Inhibition.

Rao N, Iwenofu H, Tang B, Woyach J, Liebner DA. Rao N, et al. Among authors: Liebner DA. J Natl Compr Canc Netw. 2018 Feb;16(2):115-121. doi: 10.6004/jnccn.2017.7031. J Natl Compr Canc Netw. 2018. PMID: 29439172 Review.

Cite

Share

2

Angiosarcoma: A rare malignancy with protean clinical presentations.

Huntington JT, Jones C, Liebner DA, Chen JL, Pollock RE. Huntington JT, et al. Among authors: Liebner DA. J Surg Oncol. 2015 Jun;111(8):941-50. doi: 10.1002/jso.23918. Epub 2015 May 28. J Surg Oncol. 2015. PMID: 26031299 Review.

Cite

Share

3

The indications and efficacy of conventional chemotherapy in primary and recurrent sarcoma.

Liebner DA. Liebner DA. J Surg Oncol. 2015 Apr;111(5):622-31. doi: 10.1002/jso.23866. Epub 2015 Jan 8. J Surg Oncol. 2015. PMID: 25581912 Review.

Cite

Share

4

Phase 1 Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients With Brain Metastases.

Williams NL, Wuthrick EJ, Kim H, Palmer JD, Garg S, Eldredge-Hindy H, Daskalakis C, Feeney KJ, Mastrangelo MJ, Kim LJ, Sato T, Kendra KL, Olencki T, Liebner DA, Farrell CJ, Evans JJ, Judy KD, Andrews DW, Dicker AP, Werner-Wasik M, Shi W. Williams NL, et al. Among authors: Liebner DA. Int J Radiat Oncol Biol Phys. 2017 Sep 1;99(1):22-30. doi: 10.1016/j.ijrobp.2017.05.028. Epub 2017 May 26. Int J Radiat Oncol Biol Phys. 2017. PMID: 28816150 Clinical Trial.

Cite

Share

5

TP53 mutational status is predictive of pazopanib response in advanced sarcomas.

Koehler K, Liebner D, Chen JL. Koehler K, et al. Among authors: Liebner D. Ann Oncol. 2016 Mar;27(3):539-43. doi: 10.1093/annonc/mdv598. Epub 2015 Dec 8. Ann Oncol. 2016. PMID: 26646755 Free PMC article.

Cite

Share

6

Patterns of major wound complications following multidisciplinary therapy for lower extremity soft tissue sarcoma.

Miller ED, Mo X, Andonian NT, Haglund KE, Martin DD, Liebner DA, Chen JL, Iwenofu OH, Chakravarti A, Scharschmidt TJ, Mayerson JL, Pollock RE, Xu-Welliver M. Miller ED, et al. Among authors: Liebner DA. J Surg Oncol. 2016 Sep;114(3):385-91. doi: 10.1002/jso.24313. Epub 2016 May 30. J Surg Oncol. 2016. PMID: 27238092

Cite

Share

7

Analysis of BAP1 Germline Gene Mutation in Young Uveal Melanoma Patients.

Cebulla CM, Binkley EM, Pilarski R, Massengill JB, Rai K, Liebner DA, Marino MJ, Singh AD, Abdel-Rahman MH. Cebulla CM, et al. Among authors: Liebner DA. Ophthalmic Genet. 2015 Jun;36(2):126-31. doi: 10.3109/13816810.2015.1010734. Epub 2015 Feb 17. Ophthalmic Genet. 2015. PMID: 25687217 Free PMC article.

Cite

Share

8

Treatment of Ipilimumab Induced Graves' Disease in a Patient with Metastatic Melanoma.

Azmat U, Liebner D, Joehlin-Price A, Agrawal A, Nabhan F. Azmat U, et al. Among authors: Liebner D. Case Rep Endocrinol. 2016;2016:2087525. doi: 10.1155/2016/2087525. Epub 2016 Jan 11. Case Rep Endocrinol. 2016. PMID: 26881150 Free PMC article.

Cite

Share

9

Focal takotsubo cardiomyopathy with high-dose interleukin-2 therapy for malignant melanoma.

Damodaran S, Mrozek E, Liebner D, Kendra K. Damodaran S, et al. Among authors: Liebner D. J Natl Compr Canc Netw. 2014 Dec;12(12):1666-70; quiz 1670. doi: 10.6004/jnccn.2014.0168. J Natl Compr Canc Netw. 2014. PMID: 25505207

Cite

Share

10

Prospective Evaluation of the Concordance of Commercial Circulating Tumor DNA Alterations with Tumor-Based Sequencing across Multiple Soft Tissue Sarcoma Subtypes.

Demoret B, Gregg J, Liebner DA, Tinoco G, Lenobel S, Chen JL. Demoret B, et al. Among authors: Liebner DA. Cancers (Basel). 2019 Nov 21;11(12):1829. doi: 10.3390/cancers11121829. Cancers (Basel). 2019. PMID: 31766329 Free PMC article.

Cite

Share